Diabetes and obesity

• Tirzepatide – a dual incretin agonist in the management of type 2 diabetes mellitus: a review of evidence from the SURPASS trials
• The addictive potential and the neurobiological mechanisms underlying the consumption of hyperpalatable foods: Does food addiction exist?
• Patients with T2DM without present CVD but with already present risk CV-factors: case reports
• Experience with the management of patients with extreme obesity – Part 2

Table of contents